Single Dose Study of PF-05230907 in Healthy Japanese Subjects

NCT02537002 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-05230907
DRUG: PF-05230907
DRUG: Placebo

Sponsor

Pfizer